1h Free Analyst Time
The global immunotherapy drugs market is forecasted to grow by USD 220.79 billion during 2024-2029, accelerating at a CAGR of 12.4% during the forecast period. The report on the global immunotherapy drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by escalating incidence of chronic diseases and cancer, pioneering technological and therapeutic innovations, robust investment and strategic collaborations in research and development.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The global immunotherapy drugs market is segmented as below:
By End-User
- Hospitals
- Clinics
- Others
By Type
- Monoclonal antibodies
- Vaccines
- Immune checkpoint inhibitors
- Others
By Therapeutic Area
- Cancer
- Autoimmune and inflammatory diseases
- Infectious diseases
- Others
By Region
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Russia
- Spain
- The Netherlands
- Asia
- Rest of World (RoW)
The report on the global immunotherapy drugs market covers the following areas:
- Global immunotherapy drugs market sizing
- Global immunotherapy drugs market forecast
- Global immunotherapy drugs market industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by Therapeutic Area
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Chart on Overview on criticality of inputs and factors of differentiation
- Chart on Overview on factors of disruption
- Chart on Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
3.1 Market ecosystem
- Chart on Parent Market
- Data Table on - Parent Market
- Chart on Market characteristics analysis
- Chart on Value chain analysis
4 Market Sizing
4.1 Market definition
4.4 Market outlook: Forecast for 2024-2029
- Data Table on Offerings of companies included in the market definition
- Market segments
4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ million)
- Data Table on Global - Market size and forecast 2024-2029 ($ million)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
5.1 Global Immunotherapy Drugs Market 2019 - 2023
- Historic Market Size - Data Table on Global Immunotherapy Drugs Market 2019 - 2023 ($ million)
- Historic Market Size - End-user Segment 2019 - 2023 ($ million)
- Historic Market Size - Type Segment 2019 - 2023 ($ million)
- Historic Market Size - Therapeutic Area Segment 2019 - 2023 ($ million)
- Historic Market Size - Geography Segment 2019 - 2023 ($ million)
- Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
6.1 Impact of AI in global immunotherapy drugs market
7 Five Forces Analysis
7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
- Bargaining power of buyers - Impact of key factors 2024 and 2029
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
- Threat of new entrants - Impact of key factors in 2024 and 2029
- Threat of substitutes - Impact of key factors in 2024 and 2029
- Threat of rivalry - Impact of key factors in 2024 and 2029
- Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by End-user
8.1 Market segments
- Chart on End-user - Market share 2024-2029 (%)
- Data Table on End-user - Market share 2024-2029 (%)
- Chart on Comparison by End-user
- Data Table on Comparison by End-user
- Chart on Hospitals - Market size and forecast 2024-2029 ($ million)
- Data Table on Hospitals - Market size and forecast 2024-2029 ($ million)
- Chart on Hospitals - Year-over-year growth 2024-2029 (%)
- Data Table on Hospitals - Year-over-year growth 2024-2029 (%)
- Chart on Clinics - Market size and forecast 2024-2029 ($ million)
- Data Table on Clinics - Market size and forecast 2024-2029 ($ million)
- Chart on Clinics - Year-over-year growth 2024-2029 (%)
- Data Table on Clinics - Year-over-year growth 2024-2029 (%)
- Chart on Others - Market size and forecast 2024-2029 ($ million)
- Data Table on Others - Market size and forecast 2024-2029 ($ million)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
- Market opportunity by End-user ($ million)
- Data Table on Market opportunity by End-user ($ million)
9 Market Segmentation by Type
9.1 Market segments
- Chart on Type - Market share 2024-2029 (%)
- Data Table on Type - Market share 2024-2029 (%)
- Chart on Comparison by Type
- Data Table on Comparison by Type
- Chart on Monoclonal antibodies - Market size and forecast 2024-2029 ($ million)
- Data Table on Monoclonal antibodies - Market size and forecast 2024-2029 ($ million)
- Chart on Monoclonal antibodies - Year-over-year growth 2024-2029 (%)
- Data Table on Monoclonal antibodies - Year-over-year growth 2024-2029 (%)
- Chart on Vaccines - Market size and forecast 2024-2029 ($ million)
- Data Table on Vaccines - Market size and forecast 2024-2029 ($ million)
- Chart on Vaccines - Year-over-year growth 2024-2029 (%)
- Data Table on Vaccines - Year-over-year growth 2024-2029 (%)
- Chart on Immune checkpoint inhibitors - Market size and forecast 2024-2029 ($ million)
- Data Table on Immune checkpoint inhibitors - Market size and forecast 2024-2029 ($ million)
- Chart on Immune checkpoint inhibitors - Year-over-year growth 2024-2029 (%)
- Data Table on Immune checkpoint inhibitors - Year-over-year growth 2024-2029 (%)
- Chart on Others - Market size and forecast 2024-2029 ($ million)
- Data Table on Others - Market size and forecast 2024-2029 ($ million)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
- Market opportunity by Type ($ million)
- Data Table on Market opportunity by Type ($ million)
10 Market Segmentation by Therapeutic Area
10.1 Market segments
- Chart on Therapeutic Area - Market share 2024-2029 (%)
- Data Table on Therapeutic Area - Market share 2024-2029 (%)
- Chart on Comparison by Therapeutic Area
- Data Table on Comparison by Therapeutic Area
- Chart on Cancer - Market size and forecast 2024-2029 ($ million)
- Data Table on Cancer - Market size and forecast 2024-2029 ($ million)
- Chart on Cancer - Year-over-year growth 2024-2029 (%)
- Data Table on Cancer - Year-over-year growth 2024-2029 (%)
- Chart on Autoimmune and inflammatory diseases - Market size and forecast 2024-2029 ($ million)
- Data Table on Autoimmune and inflammatory diseases - Market size and forecast 2024-2029 ($ million)
- Chart on Autoimmune and inflammatory diseases - Year-over-year growth 2024-2029 (%)
- Data Table on Autoimmune and inflammatory diseases - Year-over-year growth 2024-2029 (%)
- Chart on Infectious diseases - Market size and forecast 2024-2029 ($ million)
- Data Table on Infectious diseases - Market size and forecast 2024-2029 ($ million)
- Chart on Infectious diseases - Year-over-year growth 2024-2029 (%)
- Data Table on Infectious diseases - Year-over-year growth 2024-2029 (%)
- Chart on Others - Market size and forecast 2024-2029 ($ million)
- Data Table on Others - Market size and forecast 2024-2029 ($ million)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
- Market opportunity by Therapeutic Area ($ million)
- Data Table on Market opportunity by Therapeutic Area ($ million)
11 Customer Landscape
11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
12.1 Geographic segmentation
- Chart on Market share by geography 2024-2029 (%)
- Data Table on Market share by geography 2024-2029 (%)
- Chart on Geographic comparison
- Data Table on Geographic comparison
- Chart on North America - Market size and forecast 2024-2029 ($ million)
- Data Table on North America - Market size and forecast 2024-2029 ($ million)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
- Chart on Regional Comparison - North America
- Data Table on Regional Comparison - North America
- Chart on US - Market size and forecast 2024-2029 ($ million)
- Data Table on US - Market size and forecast 2024-2029 ($ million)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
- Chart on Canada - Market size and forecast 2024-2029 ($ million)
- Data Table on Canada - Market size and forecast 2024-2029 ($ million)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
- Chart on Mexico - Market size and forecast 2024-2029 ($ million)
- Data Table on Mexico - Market size and forecast 2024-2029 ($ million)
- Chart on Mexico - Year-over-year growth 2024-2029 (%)
- Data Table on Mexico - Year-over-year growth 2024-2029 (%)
- Chart on Europe - Market size and forecast 2024-2029 ($ million)
- Data Table on Europe - Market size and forecast 2024-2029 ($ million)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
- Chart on Regional Comparison - Europe
- Data Table on Regional Comparison - Europe
- Chart on Germany - Market size and forecast 2024-2029 ($ million)
- Data Table on Germany - Market size and forecast 2024-2029 ($ million)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
- Chart on UK - Market size and forecast 2024-2029 ($ million)
- Data Table on UK - Market size and forecast 2024-2029 ($ million)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
- Chart on France - Market size and forecast 2024-2029 ($ million)
- Data Table on France - Market size and forecast 2024-2029 ($ million)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
- Chart on Italy - Market size and forecast 2024-2029 ($ million)
- Data Table on Italy - Market size and forecast 2024-2029 ($ million)
- Chart on Italy - Year-over-year growth 2024-2029 (%)
- Data Table on Italy - Year-over-year growth 2024-2029 (%)
- Chart on Russia - Market size and forecast 2024-2029 ($ million)
- Data Table on Russia - Market size and forecast 2024-2029 ($ million)
- Chart on Russia - Year-over-year growth 2024-2029 (%)
- Data Table on Russia - Year-over-year growth 2024-2029 (%)
- Chart on Spain - Market size and forecast 2024-2029 ($ million)
- Data Table on Spain - Market size and forecast 2024-2029 ($ million)
- Chart on Spain - Year-over-year growth 2024-2029 (%)
- Data Table on Spain - Year-over-year growth 2024-2029 (%)
- Chart on The Netherlands - Market size and forecast 2024-2029 ($ million)
- Data Table on The Netherlands - Market size and forecast 2024-2029 ($ million)
- Chart on The Netherlands - Year-over-year growth 2024-2029 (%)
- Data Table on The Netherlands - Year-over-year growth 2024-2029 (%)
- Chart on Asia - Market size and forecast 2024-2029 ($ million)
- Data Table on Asia - Market size and forecast 2024-2029 ($ million)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)
- Chart on Regional Comparison - Asia
- Data Table on Regional Comparison - Asia
- Chart on China - Market size and forecast 2024-2029 ($ million)
- Data Table on China - Market size and forecast 2024-2029 ($ million)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
- Chart on Japan - Market size and forecast 2024-2029 ($ million)
- Data Table on Japan - Market size and forecast 2024-2029 ($ million)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
- Chart on India - Market size and forecast 2024-2029 ($ million)
- Data Table on India - Market size and forecast 2024-2029 ($ million)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)
- Chart on South Korea - Market size and forecast 2024-2029 ($ million)
- Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
- Chart on South Korea - Year-over-year growth 2024-2029 (%)
- Data Table on South Korea - Year-over-year growth 2024-2029 (%)
- Chart on Singapore - Market size and forecast 2024-2029 ($ million)
- Data Table on Singapore - Market size and forecast 2024-2029 ($ million)
- Chart on Singapore - Year-over-year growth 2024-2029 (%)
- Data Table on Singapore - Year-over-year growth 2024-2029 (%)
- Chart on Indonesia - Market size and forecast 2024-2029 ($ million)
- Data Table on Indonesia - Market size and forecast 2024-2029 ($ million)
- Chart on Indonesia - Year-over-year growth 2024-2029 (%)
- Data Table on Indonesia - Year-over-year growth 2024-2029 (%)
- Chart on Thailand - Market size and forecast 2024-2029 ($ million)
- Data Table on Thailand - Market size and forecast 2024-2029 ($ million)
- Chart on Thailand - Year-over-year growth 2024-2029 (%)
- Data Table on Thailand - Year-over-year growth 2024-2029 (%)
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Chart on Regional Comparison - Rest of World (ROW)
- Data Table on Regional Comparison - Rest of World (ROW)
- Chart on Brazil - Market size and forecast 2024-2029 ($ million)
- Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
- Chart on Brazil - Year-over-year growth 2024-2029 (%)
- Data Table on Brazil - Year-over-year growth 2024-2029 (%)
- Chart on Saudi Arabia - Market size and forecast 2024-2029 ($ million)
- Data Table on Saudi Arabia - Market size and forecast 2024-2029 ($ million)
- Chart on Saudi Arabia - Year-over-year growth 2024-2029 (%)
- Data Table on Saudi Arabia - Year-over-year growth 2024-2029 (%)
- Chart on South Africa - Market size and forecast 2024-2029 ($ million)
- Data Table on South Africa - Market size and forecast 2024-2029 ($ million)
- Chart on South Africa - Year-over-year growth 2024-2029 (%)
- Data Table on South Africa - Year-over-year growth 2024-2029 (%)
- Chart on Turkey - Market size and forecast 2024-2029 ($ million)
- Data Table on Turkey - Market size and forecast 2024-2029 ($ million)
- Chart on Turkey - Year-over-year growth 2024-2029 (%)
- Data Table on Turkey - Year-over-year growth 2024-2029 (%)
- Chart on UAE - Market size and forecast 2024-2029 ($ million)
- Data Table on UAE - Market size and forecast 2024-2029 ($ million)
- Chart on UAE - Year-over-year growth 2024-2029 (%)
- Data Table on UAE - Year-over-year growth 2024-2029 (%)
- Chart on Australia - Market size and forecast 2024-2029 ($ million)
- Data Table on Australia - Market size and forecast 2024-2029 ($ million)
- Chart on Australia - Year-over-year growth 2024-2029 (%)
- Data Table on Australia - Year-over-year growth 2024-2029 (%)
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
13.1 Market drivers
- Escalating incidence of chronic diseases and cancer
- Pioneering technological and therapeutic innovations
- Robust investment and strategic collaborations in research and development
- High cost of treatment and reimbursement hurdles
- Mechanisms of therapeutic resistance and management of toxicities
- Complex manufacturing processes and supply chain logistics
- Impact of drivers and challenges in 2024 and 2029
- Ascendancy of personalized cancer vaccines
- Expansion and innovation in CAR-T cell therapy
- Rapid development and approval of bispecific antibodies
14 Competitive Landscape
14.1 Overview
14.2 Competitive Landscape
14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- Overview on factors of disruption
- Impact of key risks on business
15 Competitive Analysis
15.1 Companies profiled
- Companies covered
- Company ranking index
- Matrix on companies position and classification
- AbbVie Inc. - Overview
- AbbVie Inc. - Product / Service
- AbbVie Inc. - Key news
- AbbVie Inc. - Key offerings
- SWOT
- Amgen Inc. - Overview
- Amgen Inc. - Product / Service
- Amgen Inc. - Key news
- Amgen Inc. - Key offerings
- SWOT
- AstraZeneca Plc - Overview
- AstraZeneca Plc - Product / Service
- AstraZeneca Plc - Key news
- AstraZeneca Plc - Key offerings
- SWOT
- Bayer AG - Overview
- Bayer AG - Business segments
- Bayer AG - Key news
- Bayer AG - Key offerings
- Bayer AG - Segment focus
- SWOT
- BioNTech SE - Overview
- BioNTech SE - Product / Service
- BioNTech SE - Key offerings
- SWOT
- Boehringer Ingelheim GmbH - Overview
- Boehringer Ingelheim GmbH - Product / Service
- Boehringer Ingelheim GmbH - Key news
- Boehringer Ingelheim GmbH - Key offerings
- SWOT
- Bristol Myers Squibb Co. - Overview
- Bristol Myers Squibb Co. - Product / Service
- Bristol Myers Squibb Co. - Key news
- Bristol Myers Squibb Co. - Key offerings
- SWOT
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT
- Genmab AS - Overview
- Genmab AS - Product / Service
- Genmab AS - Key offerings
- SWOT
- Gilead Sciences Inc. - Overview
- Gilead Sciences Inc. - Product / Service
- Gilead Sciences Inc. - Key news
- Gilead Sciences Inc. - Key offerings
- SWOT
- GlaxoSmithKline Plc - Overview
- GlaxoSmithKline Plc - Business segments
- GlaxoSmithKline Plc - Key news
- GlaxoSmithKline Plc - Key offerings
- GlaxoSmithKline Plc - Segment focus
- SWOT
- Johnson and Johnson Services - Overview
- Johnson and Johnson Services - Business segments
- Johnson and Johnson Services - Key news
- Johnson and Johnson Services - Key offerings
- Johnson and Johnson Services - Segment focus
- SWOT
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- SWOT
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
- SWOT
- Sanofi SA - Overview
- Sanofi SA - Business segments
- Sanofi SA - Key news
- Sanofi SA - Key offerings
- Sanofi SA - Segment focus
- SWOT
16 Appendix
16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- Inclusions checklist
- Exclusions checklist
- Currency conversion rates for US$
- Research methodology
- Information sources
- Data validation
- Validation techniques employed for market sizing
- Data synthesis
- 360 degree market analysis
- List of abbreviations
List of Exhibits
Exhibit 1: Executive Summary - Chart on Market Overview
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 6: Executive Summary - Chart on Market Segmentation by Type
Exhibit 7: Executive Summary - Chart on Market Segmentation by Therapeutic Area
Exhibit 8: Executive Summary - Chart on Incremental Growth
Exhibit 9: Executive Summary - Data Table on Incremental Growth
Exhibit 10: Executive Summary - Chart on Company Market Positioning
Exhibit 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 12: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 13: Chart on Overview on factors of disruption
Exhibit 14: Chart on Impact of drivers and challenges in 2024 and 2029
Exhibit 15: Chart on Parent Market
Exhibit 16: Data Table on - Parent Market
Exhibit 17: Chart on Market characteristics analysis
Exhibit 18: Chart on Value chain analysis
Exhibit 19: Data Table on Offerings of companies included in the market definition
Exhibit 20: Market segments
Exhibit 21: Chart on Global - Market size and forecast 2024-2029 ($ million)
Exhibit 22: Data Table on Global - Market size and forecast 2024-2029 ($ million)
Exhibit 23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibit 24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibit 25: Historic Market Size - Data Table on Global Immunotherapy Drugs Market 2019 - 2023 ($ million)
Exhibit 26: Historic Market Size - End-user Segment 2019 - 2023 ($ million)
Exhibit 27: Historic Market Size - Type Segment 2019 - 2023 ($ million)
Exhibit 28: Historic Market Size - Therapeutic Area Segment 2019 - 2023 ($ million)
Exhibit 29: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
Exhibit 30: Historic Market Size - Country Segment 2019 - 2023 ($ million)
Exhibit 31: Five forces analysis - Comparison between 2024 and 2029
Exhibit 32: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibit 33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibit 34: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibit 35: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibit 36: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibit 37: Chart on Market condition - Five forces 2024 and 2029
Exhibit 38: Chart on End-user - Market share 2024-2029 (%)
Exhibit 39: Data Table on End-user - Market share 2024-2029 (%)
Exhibit 40: Chart on Comparison by End-user
Exhibit 41: Data Table on Comparison by End-user
Exhibit 42: Chart on Hospitals - Market size and forecast 2024-2029 ($ million)
Exhibit 43: Data Table on Hospitals - Market size and forecast 2024-2029 ($ million)
Exhibit 44: Chart on Hospitals - Year-over-year growth 2024-2029 (%)
Exhibit 45: Data Table on Hospitals - Year-over-year growth 2024-2029 (%)
Exhibit 46: Chart on Clinics - Market size and forecast 2024-2029 ($ million)
Exhibit 47: Data Table on Clinics - Market size and forecast 2024-2029 ($ million)
Exhibit 48: Chart on Clinics - Year-over-year growth 2024-2029 (%)
Exhibit 49: Data Table on Clinics - Year-over-year growth 2024-2029 (%)
Exhibit 50: Chart on Others - Market size and forecast 2024-2029 ($ million)
Exhibit 51: Data Table on Others - Market size and forecast 2024-2029 ($ million)
Exhibit 52: Chart on Others - Year-over-year growth 2024-2029 (%)
Exhibit 53: Data Table on Others - Year-over-year growth 2024-2029 (%)
Exhibit 54: Market opportunity by End-user ($ million)
Exhibit 55: Data Table on Market opportunity by End-user ($ million)
Exhibit 56: Chart on Type - Market share 2024-2029 (%)
Exhibit 57: Data Table on Type - Market share 2024-2029 (%)
Exhibit 58: Chart on Comparison by Type
Exhibit 59: Data Table on Comparison by Type
Exhibit 60: Chart on Monoclonal antibodies - Market size and forecast 2024-2029 ($ million)
Exhibit 61: Data Table on Monoclonal antibodies - Market size and forecast 2024-2029 ($ million)
Exhibit 62: Chart on Monoclonal antibodies - Year-over-year growth 2024-2029 (%)
Exhibit 63: Data Table on Monoclonal antibodies - Year-over-year growth 2024-2029 (%)
Exhibit 64: Chart on Vaccines - Market size and forecast 2024-2029 ($ million)
Exhibit 65: Data Table on Vaccines - Market size and forecast 2024-2029 ($ million)
Exhibit 66: Chart on Vaccines - Year-over-year growth 2024-2029 (%)
Exhibit 67: Data Table on Vaccines - Year-over-year growth 2024-2029 (%)
Exhibit 68: Chart on Immune checkpoint inhibitors - Market size and forecast 2024-2029 ($ million)
Exhibit 69: Data Table on Immune checkpoint inhibitors - Market size and forecast 2024-2029 ($ million)
Exhibit 70: Chart on Immune checkpoint inhibitors - Year-over-year growth 2024-2029 (%)
Exhibit 71: Data Table on Immune checkpoint inhibitors - Year-over-year growth 2024-2029 (%)
Exhibit 72: Chart on Others - Market size and forecast 2024-2029 ($ million)
Exhibit 73: Data Table on Others - Market size and forecast 2024-2029 ($ million)
Exhibit 74: Chart on Others - Year-over-year growth 2024-2029 (%)
Exhibit 75: Data Table on Others - Year-over-year growth 2024-2029 (%)
Exhibit 76: Market opportunity by Type ($ million)
Exhibit 77: Data Table on Market opportunity by Type ($ million)
Exhibit 78: Chart on Therapeutic Area - Market share 2024-2029 (%)
Exhibit 79: Data Table on Therapeutic Area - Market share 2024-2029 (%)
Exhibit 80: Chart on Comparison by Therapeutic Area
Exhibit 81: Data Table on Comparison by Therapeutic Area
Exhibit 82: Chart on Cancer - Market size and forecast 2024-2029 ($ million)
Exhibit 83: Data Table on Cancer - Market size and forecast 2024-2029 ($ million)
Exhibit 84: Chart on Cancer - Year-over-year growth 2024-2029 (%)
Exhibit 85: Data Table on Cancer - Year-over-year growth 2024-2029 (%)
Exhibit 86: Chart on Autoimmune and inflammatory diseases - Market size and forecast 2024-2029 ($ million)
Exhibit 87: Data Table on Autoimmune and inflammatory diseases - Market size and forecast 2024-2029 ($ million)
Exhibit 88: Chart on Autoimmune and inflammatory diseases - Year-over-year growth 2024-2029 (%)
Exhibit 89: Data Table on Autoimmune and inflammatory diseases - Year-over-year growth 2024-2029 (%)
Exhibit 90: Chart on Infectious diseases - Market size and forecast 2024-2029 ($ million)
Exhibit 91: Data Table on Infectious diseases - Market size and forecast 2024-2029 ($ million)
Exhibit 92: Chart on Infectious diseases - Year-over-year growth 2024-2029 (%)
Exhibit 93: Data Table on Infectious diseases - Year-over-year growth 2024-2029 (%)
Exhibit 94: Chart on Others - Market size and forecast 2024-2029 ($ million)
Exhibit 95: Data Table on Others - Market size and forecast 2024-2029 ($ million)
Exhibit 96: Chart on Others - Year-over-year growth 2024-2029 (%)
Exhibit 97: Data Table on Others - Year-over-year growth 2024-2029 (%)
Exhibit 98: Market opportunity by Therapeutic Area ($ million)
Exhibit 99: Data Table on Market opportunity by Therapeutic Area ($ million)
Exhibit 100: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 101: Chart on Market share by geography 2024-2029 (%)
Exhibit 102: Data Table on Market share by geography 2024-2029 (%)
Exhibit 103: Chart on Geographic comparison
Exhibit 104: Data Table on Geographic comparison
Exhibit 105: Chart on North America - Market size and forecast 2024-2029 ($ million)
Exhibit 106: Data Table on North America - Market size and forecast 2024-2029 ($ million)
Exhibit 107: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibit 108: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibit 109: Chart on Regional Comparison - North America
Exhibit 110: Data Table on Regional Comparison - North America
Exhibit 111: Chart on US - Market size and forecast 2024-2029 ($ million)
Exhibit 112: Data Table on US - Market size and forecast 2024-2029 ($ million)
Exhibit 113: Chart on US - Year-over-year growth 2024-2029 (%)
Exhibit 114: Data Table on US - Year-over-year growth 2024-2029 (%)
Exhibit 115: Chart on Canada - Market size and forecast 2024-2029 ($ million)
Exhibit 116: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Exhibit 117: Chart on Canada - Year-over-year growth 2024-2029 (%)
Exhibit 118: Data Table on Canada - Year-over-year growth 2024-2029 (%)
Exhibit 119: Chart on Mexico - Market size and forecast 2024-2029 ($ million)
Exhibit 120: Data Table on Mexico - Market size and forecast 2024-2029 ($ million)
Exhibit 121: Chart on Mexico - Year-over-year growth 2024-2029 (%)
Exhibit 122: Data Table on Mexico - Year-over-year growth 2024-2029 (%)
Exhibit 123: Chart on Europe - Market size and forecast 2024-2029 ($ million)
Exhibit 124: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Exhibit 125: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibit 126: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibit 127: Chart on Regional Comparison - Europe
Exhibit 128: Data Table on Regional Comparison - Europe
Exhibit 129: Chart on Germany - Market size and forecast 2024-2029 ($ million)
Exhibit 130: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Exhibit 131: Chart on Germany - Year-over-year growth 2024-2029 (%)
Exhibit 132: Data Table on Germany - Year-over-year growth 2024-2029 (%)
Exhibit 133: Chart on UK - Market size and forecast 2024-2029 ($ million)
Exhibit 134: Data Table on UK - Market size and forecast 2024-2029 ($ million)
Exhibit 135: Chart on UK - Year-over-year growth 2024-2029 (%)
Exhibit 136: Data Table on UK - Year-over-year growth 2024-2029 (%)
Exhibit 137: Chart on France - Market size and forecast 2024-2029 ($ million)
Exhibit 138: Data Table on France - Market size and forecast 2024-2029 ($ million)
Exhibit 139: Chart on France - Year-over-year growth 2024-2029 (%)
Exhibit 140: Data Table on France - Year-over-year growth 2024-2029 (%)
Exhibit 141: Chart on Italy - Market size and forecast 2024-2029 ($ million)
Exhibit 142: Data Table on Italy - Market size and forecast 2024-2029 ($ million)
Exhibit 143: Chart on Italy - Year-over-year growth 2024-2029 (%)
Exhibit 144: Data Table on Italy - Year-over-year growth 2024-2029 (%)
Exhibit 145: Chart on Russia - Market size and forecast 2024-2029 ($ million)
Exhibit 146: Data Table on Russia - Market size and forecast 2024-2029 ($ million)
Exhibit 147: Chart on Russia - Year-over-year growth 2024-2029 (%)
Exhibit 148: Data Table on Russia - Year-over-year growth 2024-2029 (%)
Exhibit 149: Chart on Spain - Market size and forecast 2024-2029 ($ million)
Exhibit 150: Data Table on Spain - Market size and forecast 2024-2029 ($ million)
Exhibit 151: Chart on Spain - Year-over-year growth 2024-2029 (%)
Exhibit 152: Data Table on Spain - Year-over-year growth 2024-2029 (%)
Exhibit 153: Chart on The Netherlands - Market size and forecast 2024-2029 ($ million)
Exhibit 154: Data Table on The Netherlands - Market size and forecast 2024-2029 ($ million)
Exhibit 155: Chart on The Netherlands - Year-over-year growth 2024-2029 (%)
Exhibit 156: Data Table on The Netherlands - Year-over-year growth 2024-2029 (%)
Exhibit 157: Chart on Asia - Market size and forecast 2024-2029 ($ million)
Exhibit 158: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Exhibit 159: Chart on Asia - Year-over-year growth 2024-2029 (%)
Exhibit 160: Data Table on Asia - Year-over-year growth 2024-2029 (%)
Exhibit 161: Chart on Regional Comparison - Asia
Exhibit 162: Data Table on Regional Comparison - Asia
Exhibit 163: Chart on China - Market size and forecast 2024-2029 ($ million)
Exhibit 164: Data Table on China - Market size and forecast 2024-2029 ($ million)
Exhibit 165: Chart on China - Year-over-year growth 2024-2029 (%)
Exhibit 166: Data Table on China - Year-over-year growth 2024-2029 (%)
Exhibit 167: Chart on Japan - Market size and forecast 2024-2029 ($ million)
Exhibit 168: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Exhibit 169: Chart on Japan - Year-over-year growth 2024-2029 (%)
Exhibit 170: Data Table on Japan - Year-over-year growth 2024-2029 (%)
Exhibit 171: Chart on India - Market size and forecast 2024-2029 ($ million)
Exhibit 172: Data Table on India - Market size and forecast 2024-2029 ($ million)
Exhibit 173: Chart on India - Year-over-year growth 2024-2029 (%)
Exhibit 174: Data Table on India - Year-over-year growth 2024-2029 (%)
Exhibit 175: Chart on South Korea - Market size and forecast 2024-2029 ($ million)
Exhibit 176: Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
Exhibit 177: Chart on South Korea - Year-over-year growth 2024-2029 (%)
Exhibit 178: Data Table on South Korea - Year-over-year growth 2024-2029 (%)
Exhibit 179: Chart on Singapore - Market size and forecast 2024-2029 ($ million)
Exhibit 180: Data Table on Singapore - Market size and forecast 2024-2029 ($ million)
Exhibit 181: Chart on Singapore - Year-over-year growth 2024-2029 (%)
Exhibit 182: Data Table on Singapore - Year-over-year growth 2024-2029 (%)
Exhibit 183: Chart on Indonesia - Market size and forecast 2024-2029 ($ million)
Exhibit 184: Data Table on Indonesia - Market size and forecast 2024-2029 ($ million)
Exhibit 185: Chart on Indonesia - Year-over-year growth 2024-2029 (%)
Exhibit 186: Data Table on Indonesia - Year-over-year growth 2024-2029 (%)
Exhibit 187: Chart on Thailand - Market size and forecast 2024-2029 ($ million)
Exhibit 188: Data Table on Thailand - Market size and forecast 2024-2029 ($ million)
Exhibit 189: Chart on Thailand - Year-over-year growth 2024-2029 (%)
Exhibit 190: Data Table on Thailand - Year-over-year growth 2024-2029 (%)
Exhibit 191: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibit 192: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibit 193: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibit 194: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibit 195: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 196: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 197: Chart on Brazil - Market size and forecast 2024-2029 ($ million)
Exhibit 198: Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
Exhibit 199: Chart on Brazil - Year-over-year growth 2024-2029 (%)
Exhibit 200: Data Table on Brazil - Year-over-year growth 2024-2029 (%)
Exhibit 201: Chart on Saudi Arabia - Market size and forecast 2024-2029 ($ million)
Exhibit 202: Data Table on Saudi Arabia - Market size and forecast 2024-2029 ($ million)
Exhibit 203: Chart on Saudi Arabia - Year-over-year growth 2024-2029 (%)
Exhibit 204: Data Table on Saudi Arabia - Year-over-year growth 2024-2029 (%)
Exhibit 205: Chart on South Africa - Market size and forecast 2024-2029 ($ million)
Exhibit 206: Data Table on South Africa - Market size and forecast 2024-2029 ($ million)
Exhibit 207: Chart on South Africa - Year-over-year growth 2024-2029 (%)
Exhibit 208: Data Table on South Africa - Year-over-year growth 2024-2029 (%)
Exhibit 209: Chart on Turkey - Market size and forecast 2024-2029 ($ million)
Exhibit 210: Data Table on Turkey - Market size and forecast 2024-2029 ($ million)
Exhibit 211: Chart on Turkey - Year-over-year growth 2024-2029 (%)
Exhibit 212: Data Table on Turkey - Year-over-year growth 2024-2029 (%)
Exhibit 213: Chart on UAE - Market size and forecast 2024-2029 ($ million)
Exhibit 214: Data Table on UAE - Market size and forecast 2024-2029 ($ million)
Exhibit 215: Chart on UAE - Year-over-year growth 2024-2029 (%)
Exhibit 216: Data Table on UAE - Year-over-year growth 2024-2029 (%)
Exhibit 217: Chart on Australia - Market size and forecast 2024-2029 ($ million)
Exhibit 218: Data Table on Australia - Market size and forecast 2024-2029 ($ million)
Exhibit 219: Chart on Australia - Year-over-year growth 2024-2029 (%)
Exhibit 220: Data Table on Australia - Year-over-year growth 2024-2029 (%)
Exhibit 221: Market opportunity by geography ($ million)
Exhibit 222: Data Tables on Market opportunity by geography ($ million)
Exhibit 223: Impact of drivers and challenges in 2024 and 2029
Exhibit 224: Overview on criticality of inputs and factors of differentiation
Exhibit 225: Overview on factors of disruption
Exhibit 226: Impact of key risks on business
Exhibit 227: Companies covered
Exhibit 228: Company ranking index
Exhibit 229: Matrix on companies position and classification
Exhibit 230: AbbVie Inc. - Overview
Exhibit 231: AbbVie Inc. - Product / Service
Exhibit 232: AbbVie Inc. - Key news
Exhibit 233: AbbVie Inc. - Key offerings
Exhibit 234: SWOT
Exhibit 235: Amgen Inc. - Overview
Exhibit 236: Amgen Inc. - Product / Service
Exhibit 237: Amgen Inc. - Key news
Exhibit 238: Amgen Inc. - Key offerings
Exhibit 239: SWOT
Exhibit 240: AstraZeneca Plc - Overview
Exhibit 241: AstraZeneca Plc - Product / Service
Exhibit 242: AstraZeneca Plc - Key news
Exhibit 243: AstraZeneca Plc - Key offerings
Exhibit 244: SWOT
Exhibit 245: Bayer AG - Overview
Exhibit 246: Bayer AG - Business segments
Exhibit 247: Bayer AG - Key news
Exhibit 248: Bayer AG - Key offerings
Exhibit 249: Bayer AG - Segment focus
Exhibit 250: SWOT
Exhibit 251: BioNTech SE - Overview
Exhibit 252: BioNTech SE - Product / Service
Exhibit 253: BioNTech SE - Key offerings
Exhibit 254: SWOT
Exhibit 255: Boehringer Ingelheim GmbH - Overview
Exhibit 256: Boehringer Ingelheim GmbH - Product / Service
Exhibit 257: Boehringer Ingelheim GmbH - Key news
Exhibit 258: Boehringer Ingelheim GmbH - Key offerings
Exhibit 259: SWOT
Exhibit 260: Bristol Myers Squibb Co. - Overview
Exhibit 261: Bristol Myers Squibb Co. - Product / Service
Exhibit 262: Bristol Myers Squibb Co. - Key news
Exhibit 263: Bristol Myers Squibb Co. - Key offerings
Exhibit 264: SWOT
Exhibit 265: F. Hoffmann La Roche Ltd. - Overview
Exhibit 266: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 267: F. Hoffmann La Roche Ltd. - Key news
Exhibit 268: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 269: F. Hoffmann La Roche Ltd. - Segment focus
Exhibit 270: SWOT
Exhibit 271: Genmab AS - Overview
Exhibit 272: Genmab AS - Product / Service
Exhibit 273: Genmab AS - Key offerings
Exhibit 274: SWOT
Exhibit 275: Gilead Sciences Inc. - Overview
Exhibit 276: Gilead Sciences Inc. - Product / Service
Exhibit 277: Gilead Sciences Inc. - Key news
Exhibit 278: Gilead Sciences Inc. - Key offerings
Exhibit 279: SWOT
Exhibit 280: GlaxoSmithKline Plc - Overview
Exhibit 281: GlaxoSmithKline Plc - Business segments
Exhibit 282: GlaxoSmithKline Plc - Key news
Exhibit 283: GlaxoSmithKline Plc - Key offerings
Exhibit 284: GlaxoSmithKline Plc - Segment focus
Exhibit 285: SWOT
Exhibit 286: Johnson and Johnson Services - Overview
Exhibit 287: Johnson and Johnson Services - Business segments
Exhibit 288: Johnson and Johnson Services - Key news
Exhibit 289: Johnson and Johnson Services - Key offerings
Exhibit 290: Johnson and Johnson Services - Segment focus
Exhibit 291: SWOT
Exhibit 292: Novartis AG - Overview
Exhibit 293: Novartis AG - Business segments
Exhibit 294: Novartis AG - Key news
Exhibit 295: Novartis AG - Key offerings
Exhibit 296: Novartis AG - Segment focus
Exhibit 297: SWOT
Exhibit 298: Pfizer Inc. - Overview
Exhibit 299: Pfizer Inc. - Product / Service
Exhibit 300: Pfizer Inc. - Key news
Exhibit 301: Pfizer Inc. - Key offerings
Exhibit 302: SWOT
Exhibit 303: Sanofi SA - Overview
Exhibit 304: Sanofi SA - Business segments
Exhibit 305: Sanofi SA - Key news
Exhibit 306: Sanofi SA - Key offerings
Exhibit 307: Sanofi SA - Segment focus
Exhibit 308: SWOT
Exhibit 309: Inclusions checklist
Exhibit 310: Exclusions checklist
Exhibit 311: Currency conversion rates for US$
Exhibit 312: Research methodology
Exhibit 313: Information sources
Exhibit 314: Data validation
Exhibit 315: Validation techniques employed for market sizing
Exhibit 316: Data synthesis
Exhibit 317: 360 degree market analysis
Exhibit 318: List of abbreviations
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 6: Executive Summary - Chart on Market Segmentation by Type
Exhibit 7: Executive Summary - Chart on Market Segmentation by Therapeutic Area
Exhibit 8: Executive Summary - Chart on Incremental Growth
Exhibit 9: Executive Summary - Data Table on Incremental Growth
Exhibit 10: Executive Summary - Chart on Company Market Positioning
Exhibit 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 12: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 13: Chart on Overview on factors of disruption
Exhibit 14: Chart on Impact of drivers and challenges in 2024 and 2029
Exhibit 15: Chart on Parent Market
Exhibit 16: Data Table on - Parent Market
Exhibit 17: Chart on Market characteristics analysis
Exhibit 18: Chart on Value chain analysis
Exhibit 19: Data Table on Offerings of companies included in the market definition
Exhibit 20: Market segments
Exhibit 21: Chart on Global - Market size and forecast 2024-2029 ($ million)
Exhibit 22: Data Table on Global - Market size and forecast 2024-2029 ($ million)
Exhibit 23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibit 24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibit 25: Historic Market Size - Data Table on Global Immunotherapy Drugs Market 2019 - 2023 ($ million)
Exhibit 26: Historic Market Size - End-user Segment 2019 - 2023 ($ million)
Exhibit 27: Historic Market Size - Type Segment 2019 - 2023 ($ million)
Exhibit 28: Historic Market Size - Therapeutic Area Segment 2019 - 2023 ($ million)
Exhibit 29: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
Exhibit 30: Historic Market Size - Country Segment 2019 - 2023 ($ million)
Exhibit 31: Five forces analysis - Comparison between 2024 and 2029
Exhibit 32: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibit 33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibit 34: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibit 35: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibit 36: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibit 37: Chart on Market condition - Five forces 2024 and 2029
Exhibit 38: Chart on End-user - Market share 2024-2029 (%)
Exhibit 39: Data Table on End-user - Market share 2024-2029 (%)
Exhibit 40: Chart on Comparison by End-user
Exhibit 41: Data Table on Comparison by End-user
Exhibit 42: Chart on Hospitals - Market size and forecast 2024-2029 ($ million)
Exhibit 43: Data Table on Hospitals - Market size and forecast 2024-2029 ($ million)
Exhibit 44: Chart on Hospitals - Year-over-year growth 2024-2029 (%)
Exhibit 45: Data Table on Hospitals - Year-over-year growth 2024-2029 (%)
Exhibit 46: Chart on Clinics - Market size and forecast 2024-2029 ($ million)
Exhibit 47: Data Table on Clinics - Market size and forecast 2024-2029 ($ million)
Exhibit 48: Chart on Clinics - Year-over-year growth 2024-2029 (%)
Exhibit 49: Data Table on Clinics - Year-over-year growth 2024-2029 (%)
Exhibit 50: Chart on Others - Market size and forecast 2024-2029 ($ million)
Exhibit 51: Data Table on Others - Market size and forecast 2024-2029 ($ million)
Exhibit 52: Chart on Others - Year-over-year growth 2024-2029 (%)
Exhibit 53: Data Table on Others - Year-over-year growth 2024-2029 (%)
Exhibit 54: Market opportunity by End-user ($ million)
Exhibit 55: Data Table on Market opportunity by End-user ($ million)
Exhibit 56: Chart on Type - Market share 2024-2029 (%)
Exhibit 57: Data Table on Type - Market share 2024-2029 (%)
Exhibit 58: Chart on Comparison by Type
Exhibit 59: Data Table on Comparison by Type
Exhibit 60: Chart on Monoclonal antibodies - Market size and forecast 2024-2029 ($ million)
Exhibit 61: Data Table on Monoclonal antibodies - Market size and forecast 2024-2029 ($ million)
Exhibit 62: Chart on Monoclonal antibodies - Year-over-year growth 2024-2029 (%)
Exhibit 63: Data Table on Monoclonal antibodies - Year-over-year growth 2024-2029 (%)
Exhibit 64: Chart on Vaccines - Market size and forecast 2024-2029 ($ million)
Exhibit 65: Data Table on Vaccines - Market size and forecast 2024-2029 ($ million)
Exhibit 66: Chart on Vaccines - Year-over-year growth 2024-2029 (%)
Exhibit 67: Data Table on Vaccines - Year-over-year growth 2024-2029 (%)
Exhibit 68: Chart on Immune checkpoint inhibitors - Market size and forecast 2024-2029 ($ million)
Exhibit 69: Data Table on Immune checkpoint inhibitors - Market size and forecast 2024-2029 ($ million)
Exhibit 70: Chart on Immune checkpoint inhibitors - Year-over-year growth 2024-2029 (%)
Exhibit 71: Data Table on Immune checkpoint inhibitors - Year-over-year growth 2024-2029 (%)
Exhibit 72: Chart on Others - Market size and forecast 2024-2029 ($ million)
Exhibit 73: Data Table on Others - Market size and forecast 2024-2029 ($ million)
Exhibit 74: Chart on Others - Year-over-year growth 2024-2029 (%)
Exhibit 75: Data Table on Others - Year-over-year growth 2024-2029 (%)
Exhibit 76: Market opportunity by Type ($ million)
Exhibit 77: Data Table on Market opportunity by Type ($ million)
Exhibit 78: Chart on Therapeutic Area - Market share 2024-2029 (%)
Exhibit 79: Data Table on Therapeutic Area - Market share 2024-2029 (%)
Exhibit 80: Chart on Comparison by Therapeutic Area
Exhibit 81: Data Table on Comparison by Therapeutic Area
Exhibit 82: Chart on Cancer - Market size and forecast 2024-2029 ($ million)
Exhibit 83: Data Table on Cancer - Market size and forecast 2024-2029 ($ million)
Exhibit 84: Chart on Cancer - Year-over-year growth 2024-2029 (%)
Exhibit 85: Data Table on Cancer - Year-over-year growth 2024-2029 (%)
Exhibit 86: Chart on Autoimmune and inflammatory diseases - Market size and forecast 2024-2029 ($ million)
Exhibit 87: Data Table on Autoimmune and inflammatory diseases - Market size and forecast 2024-2029 ($ million)
Exhibit 88: Chart on Autoimmune and inflammatory diseases - Year-over-year growth 2024-2029 (%)
Exhibit 89: Data Table on Autoimmune and inflammatory diseases - Year-over-year growth 2024-2029 (%)
Exhibit 90: Chart on Infectious diseases - Market size and forecast 2024-2029 ($ million)
Exhibit 91: Data Table on Infectious diseases - Market size and forecast 2024-2029 ($ million)
Exhibit 92: Chart on Infectious diseases - Year-over-year growth 2024-2029 (%)
Exhibit 93: Data Table on Infectious diseases - Year-over-year growth 2024-2029 (%)
Exhibit 94: Chart on Others - Market size and forecast 2024-2029 ($ million)
Exhibit 95: Data Table on Others - Market size and forecast 2024-2029 ($ million)
Exhibit 96: Chart on Others - Year-over-year growth 2024-2029 (%)
Exhibit 97: Data Table on Others - Year-over-year growth 2024-2029 (%)
Exhibit 98: Market opportunity by Therapeutic Area ($ million)
Exhibit 99: Data Table on Market opportunity by Therapeutic Area ($ million)
Exhibit 100: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 101: Chart on Market share by geography 2024-2029 (%)
Exhibit 102: Data Table on Market share by geography 2024-2029 (%)
Exhibit 103: Chart on Geographic comparison
Exhibit 104: Data Table on Geographic comparison
Exhibit 105: Chart on North America - Market size and forecast 2024-2029 ($ million)
Exhibit 106: Data Table on North America - Market size and forecast 2024-2029 ($ million)
Exhibit 107: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibit 108: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibit 109: Chart on Regional Comparison - North America
Exhibit 110: Data Table on Regional Comparison - North America
Exhibit 111: Chart on US - Market size and forecast 2024-2029 ($ million)
Exhibit 112: Data Table on US - Market size and forecast 2024-2029 ($ million)
Exhibit 113: Chart on US - Year-over-year growth 2024-2029 (%)
Exhibit 114: Data Table on US - Year-over-year growth 2024-2029 (%)
Exhibit 115: Chart on Canada - Market size and forecast 2024-2029 ($ million)
Exhibit 116: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Exhibit 117: Chart on Canada - Year-over-year growth 2024-2029 (%)
Exhibit 118: Data Table on Canada - Year-over-year growth 2024-2029 (%)
Exhibit 119: Chart on Mexico - Market size and forecast 2024-2029 ($ million)
Exhibit 120: Data Table on Mexico - Market size and forecast 2024-2029 ($ million)
Exhibit 121: Chart on Mexico - Year-over-year growth 2024-2029 (%)
Exhibit 122: Data Table on Mexico - Year-over-year growth 2024-2029 (%)
Exhibit 123: Chart on Europe - Market size and forecast 2024-2029 ($ million)
Exhibit 124: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Exhibit 125: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibit 126: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibit 127: Chart on Regional Comparison - Europe
Exhibit 128: Data Table on Regional Comparison - Europe
Exhibit 129: Chart on Germany - Market size and forecast 2024-2029 ($ million)
Exhibit 130: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Exhibit 131: Chart on Germany - Year-over-year growth 2024-2029 (%)
Exhibit 132: Data Table on Germany - Year-over-year growth 2024-2029 (%)
Exhibit 133: Chart on UK - Market size and forecast 2024-2029 ($ million)
Exhibit 134: Data Table on UK - Market size and forecast 2024-2029 ($ million)
Exhibit 135: Chart on UK - Year-over-year growth 2024-2029 (%)
Exhibit 136: Data Table on UK - Year-over-year growth 2024-2029 (%)
Exhibit 137: Chart on France - Market size and forecast 2024-2029 ($ million)
Exhibit 138: Data Table on France - Market size and forecast 2024-2029 ($ million)
Exhibit 139: Chart on France - Year-over-year growth 2024-2029 (%)
Exhibit 140: Data Table on France - Year-over-year growth 2024-2029 (%)
Exhibit 141: Chart on Italy - Market size and forecast 2024-2029 ($ million)
Exhibit 142: Data Table on Italy - Market size and forecast 2024-2029 ($ million)
Exhibit 143: Chart on Italy - Year-over-year growth 2024-2029 (%)
Exhibit 144: Data Table on Italy - Year-over-year growth 2024-2029 (%)
Exhibit 145: Chart on Russia - Market size and forecast 2024-2029 ($ million)
Exhibit 146: Data Table on Russia - Market size and forecast 2024-2029 ($ million)
Exhibit 147: Chart on Russia - Year-over-year growth 2024-2029 (%)
Exhibit 148: Data Table on Russia - Year-over-year growth 2024-2029 (%)
Exhibit 149: Chart on Spain - Market size and forecast 2024-2029 ($ million)
Exhibit 150: Data Table on Spain - Market size and forecast 2024-2029 ($ million)
Exhibit 151: Chart on Spain - Year-over-year growth 2024-2029 (%)
Exhibit 152: Data Table on Spain - Year-over-year growth 2024-2029 (%)
Exhibit 153: Chart on The Netherlands - Market size and forecast 2024-2029 ($ million)
Exhibit 154: Data Table on The Netherlands - Market size and forecast 2024-2029 ($ million)
Exhibit 155: Chart on The Netherlands - Year-over-year growth 2024-2029 (%)
Exhibit 156: Data Table on The Netherlands - Year-over-year growth 2024-2029 (%)
Exhibit 157: Chart on Asia - Market size and forecast 2024-2029 ($ million)
Exhibit 158: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Exhibit 159: Chart on Asia - Year-over-year growth 2024-2029 (%)
Exhibit 160: Data Table on Asia - Year-over-year growth 2024-2029 (%)
Exhibit 161: Chart on Regional Comparison - Asia
Exhibit 162: Data Table on Regional Comparison - Asia
Exhibit 163: Chart on China - Market size and forecast 2024-2029 ($ million)
Exhibit 164: Data Table on China - Market size and forecast 2024-2029 ($ million)
Exhibit 165: Chart on China - Year-over-year growth 2024-2029 (%)
Exhibit 166: Data Table on China - Year-over-year growth 2024-2029 (%)
Exhibit 167: Chart on Japan - Market size and forecast 2024-2029 ($ million)
Exhibit 168: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Exhibit 169: Chart on Japan - Year-over-year growth 2024-2029 (%)
Exhibit 170: Data Table on Japan - Year-over-year growth 2024-2029 (%)
Exhibit 171: Chart on India - Market size and forecast 2024-2029 ($ million)
Exhibit 172: Data Table on India - Market size and forecast 2024-2029 ($ million)
Exhibit 173: Chart on India - Year-over-year growth 2024-2029 (%)
Exhibit 174: Data Table on India - Year-over-year growth 2024-2029 (%)
Exhibit 175: Chart on South Korea - Market size and forecast 2024-2029 ($ million)
Exhibit 176: Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
Exhibit 177: Chart on South Korea - Year-over-year growth 2024-2029 (%)
Exhibit 178: Data Table on South Korea - Year-over-year growth 2024-2029 (%)
Exhibit 179: Chart on Singapore - Market size and forecast 2024-2029 ($ million)
Exhibit 180: Data Table on Singapore - Market size and forecast 2024-2029 ($ million)
Exhibit 181: Chart on Singapore - Year-over-year growth 2024-2029 (%)
Exhibit 182: Data Table on Singapore - Year-over-year growth 2024-2029 (%)
Exhibit 183: Chart on Indonesia - Market size and forecast 2024-2029 ($ million)
Exhibit 184: Data Table on Indonesia - Market size and forecast 2024-2029 ($ million)
Exhibit 185: Chart on Indonesia - Year-over-year growth 2024-2029 (%)
Exhibit 186: Data Table on Indonesia - Year-over-year growth 2024-2029 (%)
Exhibit 187: Chart on Thailand - Market size and forecast 2024-2029 ($ million)
Exhibit 188: Data Table on Thailand - Market size and forecast 2024-2029 ($ million)
Exhibit 189: Chart on Thailand - Year-over-year growth 2024-2029 (%)
Exhibit 190: Data Table on Thailand - Year-over-year growth 2024-2029 (%)
Exhibit 191: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibit 192: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibit 193: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibit 194: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibit 195: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 196: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 197: Chart on Brazil - Market size and forecast 2024-2029 ($ million)
Exhibit 198: Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
Exhibit 199: Chart on Brazil - Year-over-year growth 2024-2029 (%)
Exhibit 200: Data Table on Brazil - Year-over-year growth 2024-2029 (%)
Exhibit 201: Chart on Saudi Arabia - Market size and forecast 2024-2029 ($ million)
Exhibit 202: Data Table on Saudi Arabia - Market size and forecast 2024-2029 ($ million)
Exhibit 203: Chart on Saudi Arabia - Year-over-year growth 2024-2029 (%)
Exhibit 204: Data Table on Saudi Arabia - Year-over-year growth 2024-2029 (%)
Exhibit 205: Chart on South Africa - Market size and forecast 2024-2029 ($ million)
Exhibit 206: Data Table on South Africa - Market size and forecast 2024-2029 ($ million)
Exhibit 207: Chart on South Africa - Year-over-year growth 2024-2029 (%)
Exhibit 208: Data Table on South Africa - Year-over-year growth 2024-2029 (%)
Exhibit 209: Chart on Turkey - Market size and forecast 2024-2029 ($ million)
Exhibit 210: Data Table on Turkey - Market size and forecast 2024-2029 ($ million)
Exhibit 211: Chart on Turkey - Year-over-year growth 2024-2029 (%)
Exhibit 212: Data Table on Turkey - Year-over-year growth 2024-2029 (%)
Exhibit 213: Chart on UAE - Market size and forecast 2024-2029 ($ million)
Exhibit 214: Data Table on UAE - Market size and forecast 2024-2029 ($ million)
Exhibit 215: Chart on UAE - Year-over-year growth 2024-2029 (%)
Exhibit 216: Data Table on UAE - Year-over-year growth 2024-2029 (%)
Exhibit 217: Chart on Australia - Market size and forecast 2024-2029 ($ million)
Exhibit 218: Data Table on Australia - Market size and forecast 2024-2029 ($ million)
Exhibit 219: Chart on Australia - Year-over-year growth 2024-2029 (%)
Exhibit 220: Data Table on Australia - Year-over-year growth 2024-2029 (%)
Exhibit 221: Market opportunity by geography ($ million)
Exhibit 222: Data Tables on Market opportunity by geography ($ million)
Exhibit 223: Impact of drivers and challenges in 2024 and 2029
Exhibit 224: Overview on criticality of inputs and factors of differentiation
Exhibit 225: Overview on factors of disruption
Exhibit 226: Impact of key risks on business
Exhibit 227: Companies covered
Exhibit 228: Company ranking index
Exhibit 229: Matrix on companies position and classification
Exhibit 230: AbbVie Inc. - Overview
Exhibit 231: AbbVie Inc. - Product / Service
Exhibit 232: AbbVie Inc. - Key news
Exhibit 233: AbbVie Inc. - Key offerings
Exhibit 234: SWOT
Exhibit 235: Amgen Inc. - Overview
Exhibit 236: Amgen Inc. - Product / Service
Exhibit 237: Amgen Inc. - Key news
Exhibit 238: Amgen Inc. - Key offerings
Exhibit 239: SWOT
Exhibit 240: AstraZeneca Plc - Overview
Exhibit 241: AstraZeneca Plc - Product / Service
Exhibit 242: AstraZeneca Plc - Key news
Exhibit 243: AstraZeneca Plc - Key offerings
Exhibit 244: SWOT
Exhibit 245: Bayer AG - Overview
Exhibit 246: Bayer AG - Business segments
Exhibit 247: Bayer AG - Key news
Exhibit 248: Bayer AG - Key offerings
Exhibit 249: Bayer AG - Segment focus
Exhibit 250: SWOT
Exhibit 251: BioNTech SE - Overview
Exhibit 252: BioNTech SE - Product / Service
Exhibit 253: BioNTech SE - Key offerings
Exhibit 254: SWOT
Exhibit 255: Boehringer Ingelheim GmbH - Overview
Exhibit 256: Boehringer Ingelheim GmbH - Product / Service
Exhibit 257: Boehringer Ingelheim GmbH - Key news
Exhibit 258: Boehringer Ingelheim GmbH - Key offerings
Exhibit 259: SWOT
Exhibit 260: Bristol Myers Squibb Co. - Overview
Exhibit 261: Bristol Myers Squibb Co. - Product / Service
Exhibit 262: Bristol Myers Squibb Co. - Key news
Exhibit 263: Bristol Myers Squibb Co. - Key offerings
Exhibit 264: SWOT
Exhibit 265: F. Hoffmann La Roche Ltd. - Overview
Exhibit 266: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 267: F. Hoffmann La Roche Ltd. - Key news
Exhibit 268: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 269: F. Hoffmann La Roche Ltd. - Segment focus
Exhibit 270: SWOT
Exhibit 271: Genmab AS - Overview
Exhibit 272: Genmab AS - Product / Service
Exhibit 273: Genmab AS - Key offerings
Exhibit 274: SWOT
Exhibit 275: Gilead Sciences Inc. - Overview
Exhibit 276: Gilead Sciences Inc. - Product / Service
Exhibit 277: Gilead Sciences Inc. - Key news
Exhibit 278: Gilead Sciences Inc. - Key offerings
Exhibit 279: SWOT
Exhibit 280: GlaxoSmithKline Plc - Overview
Exhibit 281: GlaxoSmithKline Plc - Business segments
Exhibit 282: GlaxoSmithKline Plc - Key news
Exhibit 283: GlaxoSmithKline Plc - Key offerings
Exhibit 284: GlaxoSmithKline Plc - Segment focus
Exhibit 285: SWOT
Exhibit 286: Johnson and Johnson Services - Overview
Exhibit 287: Johnson and Johnson Services - Business segments
Exhibit 288: Johnson and Johnson Services - Key news
Exhibit 289: Johnson and Johnson Services - Key offerings
Exhibit 290: Johnson and Johnson Services - Segment focus
Exhibit 291: SWOT
Exhibit 292: Novartis AG - Overview
Exhibit 293: Novartis AG - Business segments
Exhibit 294: Novartis AG - Key news
Exhibit 295: Novartis AG - Key offerings
Exhibit 296: Novartis AG - Segment focus
Exhibit 297: SWOT
Exhibit 298: Pfizer Inc. - Overview
Exhibit 299: Pfizer Inc. - Product / Service
Exhibit 300: Pfizer Inc. - Key news
Exhibit 301: Pfizer Inc. - Key offerings
Exhibit 302: SWOT
Exhibit 303: Sanofi SA - Overview
Exhibit 304: Sanofi SA - Business segments
Exhibit 305: Sanofi SA - Key news
Exhibit 306: Sanofi SA - Key offerings
Exhibit 307: Sanofi SA - Segment focus
Exhibit 308: SWOT
Exhibit 309: Inclusions checklist
Exhibit 310: Exclusions checklist
Exhibit 311: Currency conversion rates for US$
Exhibit 312: Research methodology
Exhibit 313: Information sources
Exhibit 314: Data validation
Exhibit 315: Validation techniques employed for market sizing
Exhibit 316: Data synthesis
Exhibit 317: 360 degree market analysis
Exhibit 318: List of abbreviations
Executive Summary
The following companies are recognized as the key players in the global global immunotherapy drugs market: AbbVie Inc., Amgen Inc., AstraZeneca Plc, Bayer AG, BioNTech SE, Boehringer Ingelheim GmbH, Bristol Myers Squibb Co., Celldex Therapeutics Inc, F. Hoffmann La Roche Ltd., Genmab AS, Gilead Sciences Inc., GlaxoSmithKline Plc, Incyte Corp., Johnson and Johnson Services, Novartis AG, Pfizer Inc., Sanofi SA, Teva Pharmaceutical Ltd..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is ascendancy of personalized cancer vaccines."
According to the report, one of the major drivers for this market is the escalating incidence of chronic diseases and cancer.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie Inc.
- Amgen Inc.
- AstraZeneca Plc
- Bayer AG
- BioNTech SE
- Boehringer Ingelheim GmbH
- Bristol Myers Squibb Co.
- Celldex Therapeutics Inc
- F. Hoffmann La Roche Ltd.
- Genmab AS
- Gilead Sciences Inc.
- GlaxoSmithKline Plc
- Incyte Corp.
- Johnson and Johnson Services
- Novartis AG
- Pfizer Inc.
- Sanofi SA
- Teva Pharmaceutical Ltd.
